A surrogate marker of protection confirms the efficacy of an AddaS03-adjuvanted West Nile virus subunit vaccine
Atsuko Inoue, Shinji Saito, Kaito Maeda, Yukari Itakura, Shintaro Kobayashi, Michihito Sasaki, Gabriel González, William W. Hall, Katsumi Maenaka, Yasuko Orba, Hirofumi Sawa, Koshiro Tabata
This study evaluates AddaS03 as an adjuvant for a WNV subunit vaccine, showing it elicits higher neutralizing antibody titers and provides full protection in mice compared to Alhydrogel.
bioRxiv · Apr 21, 2026 · PreprintMicrobiology